OUR STORY
In 2013, the Biomaterials and Bioengineering Laboratory of the French National Institute for Health and Medical Research (Inserm UMR 1121), co-directed by our CSO, Dr. Philippe LAVALLE, discovered the antimicrobial properties of the anti-inflammatory coatings we were working on.
Between 2016 and 2018, we worked to develop our technology with the support of SATT Conectus .
In 2019, our CEO, Dr Nihal Engin Vrana, together with 2 collaborators, Dr Philippe Lavalle and Dr Angela Mutschler created SPARTHA Medical and were then incubated at SEMIA.
2020: TEAM UP
In 2020, the team has expanded with a production manager, Ms Cynthia Calligaro; a Business Developer, Dr Pulchérie Matsodoum Nguemté and a CFO, Mr Thierry Mignot.
We have been privileged to gather a multidisciplinary and experienced scientific advisory board.
In 2021, SPARTHA Medical obtained CIR accreditation for research and development (R&D) after scientific and technical expertise.
2021: TEAM UP
At the end of 2021, SPARTHA Medical welcomed 4 new full-time staff:
- Dr Baptiste Letellier, as project manager, responsible for collaborative projects,
- Ms Lucie Lieu, as an apprentice engineer in biotechnology,
- Ms Yijie Li, a PhD candidate in mechanical engineering,
- Ms Ribsimé Mesropian, as an apprentice in marketing and communication.
OUR TEAM
Scientific Advisory Board
Strategic Advisory Board
OUR PARTNERS
RESEARCH SUPPORTS
TerminAnion Project
Unité de recherche UMR S1110
Institut de Recherche sur les Maladie Virales et Hépatiques
For more Informations : CONTACT US